APAS Independence
AI-powered automated culture plate reading system for microbiology labs
Company profile
Company profile
Clever Culture Systems is a leader in microbiology technology driven by artificial intelligence, specializing in automated culture plate reading solutions for pharmaceutical manufacturing and clinical laboratories. The company's flagship product, APAS Independence (Automated Plate Assessment System), is a world-leading in-vitro diagnostic instrument that automates the imaging, analysis, and interpretation of agar culture plates following incubation. Designed by microbiologists for microbiologists, the system uses advanced imaging and sophisticated AI algorithms to identify, interpret, and count microbial growth on culture media, processing up to 200 plates per hour without manual intervention. The technology serves pharmaceutical quality control laboratories for environmental monitoring and clinical microbiology labs for applications including urine screening, infection control, and antimicrobial susceptibility testing. APAS Independence has achieved regulatory clearances from the US FDA, CE Marking under IVDR, MHRA registration in the UK, and ARTG listing in Australia. The system integrates with laboratory information management systems (LIMS) to provide real-time reporting, enhanced data integrity, and complete traceability through digital plate images. The company's technology is scientifically validated and referenced in over 25 publications in leading academic journals, offering laboratories improved efficiency, standardization, and staff satisfaction by automating time-consuming, repetitive culture plate reading tasks.
Company description Clever Culture Systems official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded · On Premise deployment with recorded integration context.
Recorded integration context: LIMS (Laboratory Information Management Systems) - multiple formats.
Company milestones
Achieved CE Marking under new IVDR regulations. Multiple regulatory clearances across US, Europe, UK, and Australia.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered automated culture plate reading system for microbiology labs
AI-enabled software for clinical microbiology plate analysis
AI-enabled software for pharmaceutical environmental monitoring plate analysis
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
PDA journal of pharmaceutical science and technology · Aug 7, 2026
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A.Genes and immunity · Dec 1, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A.Genes and immunity · Jun 1, 2025
Clinical evaluation of the APAS® Independence: Automated imaging and interpretation of urine cultures using artificial intelligence with composite reference standard discrepant resolution.Journal of microbiological methods · Oct 1, 2020
Clinical validation
No linked records are currently available.
Regulatory
K183648 · 510k · May 15, 2019
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
200 plates per hour vs manual handling
Reduced human error with digital audit trail
MRSA reads managed by one staff member instead of multiple
Real-time reporting to LIMS as plates are processed
MRSA screening automation to redeploy staff to higher-value work
Able to manage MRSA reads using only one staff member, enabling redeployment to developmental projects
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Clever Culture Systems's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.